Tumor-targeted gene delivery using poly(ethylene glycol)-modified gelatin nanoparticles: In Vitro and in Vivo studies

Pharmaceutical Research

Volumn 22, Issue 6, 2005, Pages 951-961

  Kaul, Goldie ^a,b   Amiji, Mansoor ^a  

^a NORTHEASTERN UNIVERSITY   (United States)

^b BOSTON SCIENTIFIC CORPORATION   (United States)

Author keywords

Lewis lung carcinoma model; Nonviral delivery; PEG modified gelatin nanoparticles; Plasmid DNA; Tumor targeting

Indexed keywords

2 NITROPHENOL; 2 NITROPHENYLGALACTOSIDE; ALCOHOL; BETA GALACTOSIDASE; GALACTOSIDE; GELATIN; MACROGOL; NANOPARTICLE; PLASMID DNA; RECOMBINANT DNA; SOLVENT; UNCLASSIFIED DRUG; WATER;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER CELL CULTURE; CARCINOMA CELL; CONTROLLED STUDY; ENCAPSULATION; ENZYMATIC ASSAY; FEMALE; GENE EXPRESSION; GENETIC TRANSFECTION; LEWIS CARCINOMA; LIVER; MOUSE; NONHUMAN; NONVIRAL GENE DELIVERY SYSTEM; NONVIRAL GENE THERAPY; PH; PRIORITY JOURNAL; PROTEIN EXPRESSION; QUALITATIVE ANALYSIS; QUANTITATIVE ANALYSIS; STAINING; TEMPERATURE; TRANSGENE; TUMOR VOLUME;

ANIMALS; BETA-GALACTOSIDASE; CARCINOMA, LEWIS LUNG; DATA INTERPRETATION, STATISTICAL; DNA, NEOPLASM; DRUG DELIVERY SYSTEMS; EXCIPIENTS; FEMALE; GELATIN; GENE THERAPY; HUMANS; MICE; MICROSPHERES; PARTICLE SIZE; PLASMIDS; POLYETHYLENE GLYCOLS; TRANSFECTION; TRANSGENES;

EID: 21244448447     PISSN: 07248741     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11095-005-4590-3     Document Type: Article

References (40)

1. A. C. von Eschenbach 2004 A vision for the national cancer program in the United States Nat. Rev. Cancer 4 820 828
2. J. Baselga 1999 New horizons: gene therapy for cancer Anti-Cancer Drugs 10 S39 S42
3. B. E. Huber 1994 Gene therapy strategies for treating neoplastic diseases Ann. N.Y. Acad. Sci. 716 6 11
4. J. A. Roth R. J. Christiano 1997 Gene therapy for cancer: what have we done and where are we going? J. Natl. Cancer Inst. 89 21 39
5. R. J. Mrsny 2004 Tissue- and cell-specific targeting for the delivery of genetic information M. M. Amiji Polymeric Gene Delivery: Principles and Applications CRC Press, LLC Boca Raton, FL 5 27
6. E. Marshall 2000 Gene therapy on trial Science 288 951 956
7. E. Check 2002 Gene therapy: a tragic setback Nature 420 116 118
8. F. D. Ledley 1994 Non-viral gene therapy Curr. Opin. Biotechnol. 5 626 636
9. M. Nishikawa M. Hashida 2002 Nonviral approaches satisfying various requirements for effective in vivo gene therapy Biol. Pharm. Bull. 25 275 283
10. Y. Kaneda 2004 Biological barriers to gene transfer M. M. Amiji Polymeric Gene Delivery: Principles and Applications CRC Press, LLC Boca Raton, FL 29 41
11. A. G. Schatzlein 2003 Targeting of synthetic gene delivery systems J. Biomed. Biotechnol. 2 149 158
12. D. Luo W. M. Saltzman 2000 Synthetic DNA delivery systems Nat. Biotechnol. 18 33 37
13. S. Dokka Y. Rojanasakul 2004 Cellular uptake and trafficking M. M. Amiji Polymeric Gene Delivery: Principles and Applications CRC Press, LLC Boca Raton, FL 43 61
14. A. G. Schatzlein 2001 Non-viral vectors in cancer gene therapy: principles and progress Anti-Cancer Drugs 12 275 304
15. A. T. Jones M. Gumbleton R. Duncan 2003 Understanding endocytic pathways and intracellular trafficking: a prerequisite for effective design of advanced drug delivery systems Adv. Drug Deliv. Rev. 55 1353 1357
16. J. Panyam V. Labhasetwar 2003 Biodegradable nanoparticles for drug and gene delivery to cells and tissue Adv. Drug Deliv. Rev. 55 329 352
17. R. Gref Y. Minamitake M. T. Peracchia V. S. Trubetskoy V. P. Torchilin R. Langer 1994 Biodegradable long-circulating polymeric nanospheres Science 263 1600 1603
18. S. M. Moghimi A. C. Hunter J. C. Murray 2001 Long-circulating and target-specific nanoparticles: theory to practice Pharmacol. Rev. 53 283 318
19. H. Otsuka Y. Nagasaki K. Kataoka 2003 PEGylated nanoparticles for biological and pharmaceutical applications Adv. Drug Deliv. Rev. 55 403 419
20. T. Nomura N. Koreeda F. Yamashita Y. Takakura M. Hashida 1998 Effect of particle size and charge on the disposition of lipid carriers after intratumoral injection into tissue-isolated tumors Pharm. Res. 15 128 132
21. H. Maeda J. Wu T. Sawa Y. Matsumura K. Hori 2000 Tumor vascular permeability and the EPR effect in macromolecular therapeutics: a review J. Control. Release 65 271 284
22. L. W. Seymour 1992 Passive tumor targeting of soluble macromolecules and drug conjugates Crit. Rev. Ther. Drug Carr. Syst. 9 135 187
23. R. Duncan Y.-N. Sat 1998 Tumor targeting by enhanced permeability and retention (EPR) effect Ann. Oncol. 9 39 50
24. F. Yuan M. Dellian D. Fukumura M. Leunig D. A. Berk V. P. Torchilin R. K. Jain 1995 Vascular permeability in a human tumor xenograft: molecular size dependence and cutoff size Cancer Res. 55 3752 3756
25. W. L. Monsky D. Fukumura T. Gohongi M. Ancukiewcz H. A. Weich V. P. Torchilin R. K. Jain 1999 Augmentation of transvascular transport of macromolecules and nanoparticles in tumors using vascular endothelial growth factor Cancer Res. 59 4129 4135
26. M. Dellian F. Yuan V. S. Trubetskoy V. P. Torchilin R. K. Jain 2000 Vascular permeability in a human tumor xenograft: molecular charge dependence Br. J. Cancer 82 1513 1518
27. G. Kaul M. Amiji 2004 Polymeric gene delivery systems D. L. Wise V. Hasirci K.-U. Lewandrowski M. J. Yaszemski D. W. Altobelli D. J. Trantolo Tissue Engineering and Novel Delivery Systems Marcel Dekker, Inc. New York, NY 333 367
28. G. Kaul M. Amiji 2004 Protein nanospheres for gene delivery M. M. Amiji Polymeric Gene Delivery: Principles and Applications CRC Press, LLC Boca Raton, FL 429 447
29. A. Veis 1964 The Macromolecular Chemistry of Gelatin Academic Press Inc. New York, NY
30. A. G. Ward A. Courts 1977 The Science and Technology of Gelatin Academic Press, Inc. New York, NY
31. G. Kaul M. Amiji 2002 Long-circulating poly(ethylene glycol)-modified gelatin nanoparticles for intracellular delivery Pharm. Res. 19 1062 1068
32. G. Kaul C. Lee-Parsons M. Amiji 2003 Poly(ethylene glycol)-modified gelatin nanoparticles for intracellular delivery Pharm. Eng. 23 108 114
33. G. Kaul M. Amiji 2005 Cellular interactions and in vitro DNA transfection studies with poly(ethylene glycol)-modified gelatin nanoparticles J. Pharm. Sci. 94 184 198
34. G. Kaul M. Amiji 2004 Biodistribution and targeting potential of poly(ethylene glycol) modified gelatin nanoparticles in subcutaneous murine tumor model J. Drug Target. 12 585 591
35. D. A. Nielsen J. Chou A. J. MacKrell M. J. Casadaban D. F. Steiner 1983 Expression of a preproinsulin-b-galactosidase gene fusion in mammalian cells Proc. Natl. Acad. Sci. USA 80 5198 5202
36. R. Krishna M. S. Webb G. St. Onge L. D. Mayer 2001 Liposomal and nonliposomal drug pharmacokinetics after administration of liposome-encapsulated vincristine and their contribution to drug tissue disposition properties J. Pharmacol. Exp. Ther. 298 1206 1212
37. S. Nsereko M. Amiji 2002 Localized delivery of paclitaxel in solid tumors from biodegradable chitin microparticle formulations Biomaterials 23 2723 2731
38. V. Weissig K. R. Whiteman V. P. Torchilin 1998 Accumulation of protein-loaded long-circulating micelles and liposomes in subcutaneous Lewis lung carcinoma in mice Pharm. Res. 15 1552 1556
39. D. Lechardeur G. L. Lukacs 2002 Intracellular barriers to non-viral gene delivery Curr. Gene Ther. 2 183 194
40. L. Gerrace 1992 Molecular trafficking across the nuclear pore complex Curr. Opin. Cell Biol. 4 637 645